Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Future Oncology (London, England)|June 6, 2020
Nanoparticle albumin-bound paclitaxel/liposomal-encapsulated doxorubicin in HER2-negative metastatic breast cancer patientsAlessandra Fabi, Gianluigi Ferretti, Paola Malaguti, et al.
NPJ Breast Cancer|January 28, 2026
Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncologyGiuseppe Di Grazia, Rodrigo Sánchez-Bayona, Climent Casals-Pascual, et al.
Cancer Treatment Reviews|August 25, 2024
Navigating the complex relationship between human gut microbiota and breast cancer: Physiopathological, prognostic and therapeutic implicationsFrancesco Schettini, Federica Gattazzo, Sabrina Nucera, et al.
Frontiers in Oncology|August 25, 2022
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatmentCaterina Gianni, Michela Palleschi, Giuseppe Schepisi, et al.
The Pediatric Infectious Disease Journal|April 12, 2003
A multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancerElio Castagnola, Luca Boni, Mareva Giacchino, et al.
British Journal of Haematology|July 9, 2002
The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patientsAdriana Ceci, Paola Baiardi, Mariagrazia Felisi, et al.
Frontiers in Oncology|January 12, 2019
CDK 4/6 Inhibitors as Single Agent in Advanced Solid TumorsFrancesco Schettini, Irene De Santo, Carmen G Rea, et al.
International Journal of Molecular Sciences|November 11, 2022
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic TestsMariarosaria Saponaro, Luigi Annunziata, Antonella Turla, et al.
Frontiers in Oncology|September 5, 2022
Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational studyPietro De Placido, Erica Pietroluongo, Carmine De Angelis, et al.
Frontiers in Oncology|November 25, 2022
Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case reportFrancesco Schettini, Elia Seguí, Benedetta Conte, et al.
Pageof 9